Passage Bio Inc. (PASG) plunge -12.06% in a week: will this be a lucky break through?


As on November 23, 2022, Passage Bio Inc. (NASDAQ: PASG) got off with the flyer as it spiked 3.33% to $1.24. During the day, the stock rose to $1.26 and sunk to $1.18 before settling in for the price of $1.20 at the close. Taking a more long-term approach, PASG posted a 52-week range of $1.11-$8.07.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.60%. This publicly-traded company’s shares outstanding now amounts to $54.47 million, simultaneously with a float of $49.26 million. The organization now has a market capitalization sitting at $71.19 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3236, while the 200-day Moving Average is $2.2012.

Passage Bio Inc. (PASG) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Passage Bio Inc.’s current insider ownership accounts for 9.71%, in contrast to 70.70% institutional ownership. According to the most recent insider trade that took place on Sep 19, this organization’s Chief Commercial Officer sold 1,681 shares at the rate of 1.51, making the entire transaction reach 2,539 in total value, affecting insider ownership by 3,319. Preceding that transaction, on May 04, Company’s 10% Owner bought 303,500 for 1.94, making the whole transaction’s value amount to 588,790. This particular insider is now the holder of 6,841,423 in total.

Passage Bio Inc. (PASG) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 6/29/2022, the company posted -$0.73 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.83) by $0.1. This company achieved a return on equity of -59.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.

Passage Bio Inc.’s EPS decrease for this current 12-month fiscal period is -19.60% and is forecasted to reach -2.02 in the upcoming year.

Passage Bio Inc. (NASDAQ: PASG) Trading Performance Indicators

Let’s observe the current performance indicators for Passage Bio Inc. (PASG). It’s Quick Ratio in the last reported quarter now stands at 10.30. The Stock has managed to achieve an average true range (ATR) of 0.12.

In the same vein, PASG’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.95, a figure that is expected to reach -0.52 in the next quarter, and analysts are predicting that it will be -2.02 at the market close of one year from today.

Technical Analysis of Passage Bio Inc. (PASG)

Through scrutinizing the latest numbers posted by the [Passage Bio Inc., PASG], it can be observed that its last 5-days Average volume of 0.24 million was lower the volume of 0.36 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 27.52% While, its Average True Range was 0.1267.


Please enter your comment!
Please enter your name here